We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Similarweb
SMWB
$627M
| $472K | ﹤0.01% |
69,840
+46,667
| +201% | +$299K |
|
2102
Fidelity National Financial
FNF
$14.4B
| $472K | ﹤0.01% |
+13,500
| New | +$531K |
|
2103
Costco
COST
$432B
| $471K | ﹤0.01% |
948
-136,023
| -99% | -$66.7M |
|
|
VBTX
2104
DELISTED
Veritex Holdings
VBTX
| $471K | ﹤0.01% |
+25,769
| New | +$657K |
|
|
PRO
2105
DELISTED
PROS Holdings
PRO
| $469K | ﹤0.01% |
17,111
+1,411
| +9% | +$36.8K |
|
2106
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$269M
| $468K | ﹤0.01% |
14,592
+392
| +3% | +$12.7K |
|
|
GRTX
2107
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $468K | ﹤0.01% |
+182,669
| New | +$377K |
|
2108
Steel Dynamics
STLD
$36.2B
| $466K | ﹤0.01% |
+4,123
| New | +$479K |
|
|
TRUE
2109
DELISTED
TrueCar
TRUE
| $466K | ﹤0.01% |
202,536
+3,191
| +2% | +$8.51K |
|
2110
CBRE Group
CBRE
$43.3B
| $464K | ﹤0.01% |
+6,379
| New | +$521K |
|
|
UCL
2111
uCloudlink Group
UCL
$33.5M
| $462K | ﹤0.01% |
116,132
-61,577
| -35% | -$270K |
|
2112
Barrett Business Services
BBSI
$1.01B
| $461K | ﹤0.01% |
+20,820
| New | +$486K |
|
|
ESPR
2113
DELISTED
Esperion Therapeutics
ESPR
| $457K | ﹤0.01% |
287,605
+112,582
| +64% | +$581K |
|
|
BCOV
2114
DELISTED
Brightcove, Inc.
BCOV
| $456K | ﹤0.01% |
+102,392
| New | +$572K |
|
|
BNT
2115
Brookfield Wealth Solutions
BNT
$11.7B
| $453K | ﹤0.01% |
20,600
+7,043
| +52% | +$159K |
|
2116
CALL
Solid Power Inc Warrant
SLDPW
$6.02M
| $452K | ﹤0.01% |
150,000
-217,816
| -59% | -$117K |
|
2117
Ranger Energy Services
RNGR
$354M
| $448K | ﹤0.01% |
43,967
+11,169
| +34% | +$122K |
|
2118
NVE Corp
NVEC
$543M
| $445K | ﹤0.01% |
5,364
-11,332
| -68% | -$846K |
|
2119
ANI Pharmaceuticals
ANIP
$1.86B
| $445K | ﹤0.01% |
+11,199
| New | +$472K |
|
|
PDM
2120
Piedmont Realty Trust
PDM
$1.24B
| $444K | ﹤0.01% |
60,827
-346,051
| -85% | -$3.18M |
|
2121
Coastal Financial
CCB
$1.08B
| $442K | ﹤0.01% |
12,262
+921
| +8% | +$39.7K |
|
2122
Core Laboratories
CLB
$455M
| $440K | ﹤0.01% |
+19,970
| New | +$467K |
|
|
CGAU
2123
Centerra Gold
CGAU
$3.33B
| $440K | ﹤0.01% |
+67,992
| New | +$424K |
|
2124
Axsome Therapeutics
AXSM
$11.7B
| $439K | ﹤0.01% |
+7,121
| New | +$468K |
|
|
IMGN
2125
DELISTED
Immunogen Inc
IMGN
| $439K | ﹤0.01% |
114,355
-114,060
| -50% | -$486K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.